TSX/CPH (TSX/CPH)

Toronto Stock Exchange: TSX/CPH · CAD

CA$13.5

+0.36 (+2.8%)· Recorded snapshot

Market cap	342.3M
Revenue (ttm)	70.5M
Net income (ttm)	41.2M
EPS (ttm)	CA$1.59
Shares out	25.4M
P/E (trailing)	8.4x
P/E (forward)	11.2x
Volume	6,270
Beta	0.41

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 70.5M
Net income (ttm): 41.2M
EPS (ttm): CA$1.59
P/E (trailing): 8.4x
P/E (forward): 11.2x
Market cap: 342.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.2

P25 n/aP50 n/aP75 n/a

Trailing P/E8.4

P25 n/aP50 n/aP75 n/a

ROE23.5

P25 n/aP50 n/aP75 n/a

ROIC15.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/CPH indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-05
Employees	5
Employees change	-1
Employees growth	-16.67%
Enterprise value	CAD 329.9M
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA17253X1050
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Market cap	CAD 342.3M
Next earnings date	2026-11-05
Price	CAD 13.47
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/CPH

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	11.07x
Average P/E ratio (3Y)	12.69x
Average P/E ratio (5Y)	9.55x
Earnings yield	11.84%
EV/Earnings	7.79x
EV/EBIT	11.45x
EV/EBITDA	8.44x
EV/FCF	8.36x
EV/Sales	4.55x
FCF / EV yield	11.96%
FCF yield	11.51%
Forward P/E	11.22x
Graham number	16.58751
Graham upside	26.53%
Industry forward P/E	34.53x
Lynch fair value	CAD 39.86
Lynch upside	204.06%
P/(FCF - SBC) ratio	9.26x
P/(OCF - SBC) ratio	9.25x
P/B ratio	1.71x
P/E ratio	8.45x
P/FCF ratio	8.69x
P/OCF ratio	8.67x
P/S ratio	4.73x
Price / tangible book value	4.65x
Price/EBITDA ratio	8.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	39.76%
EBITDA margin	53.36%
FCF margin	55.09%
Gross margin	81.4%
Operating margin	39.76%
Pretax margin	35.19%
Profit margin	58.42%
Profit per employee	CAD 8.2M
Profitable quarters	22
Profitable years	9
Revenue per employee	CAD 14.1M
ROA	7.97%
ROA (5Y)	9.33%
ROCE	14.36%
ROE	23.5%
ROE (5Y)	27.63%
ROIC	15.46%
ROIC (5Y)	26.36%
SBC / revenue	3.4%
Tax / revenue	-23.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	140.95%
EPS growth (Q)	-31.82%
EPS growth (QoQ)	-37.5%
EPS growth 3Y	0.78%
EPS growth 5Y	41.24%
EPS growth years	1
FCF growth (Q)	-49.6%
FCF growth (QoQ)	-32.89%
FCF growth 3Y	27.27%
FCF growth 5Y	17.71%
Gross profit growth	15.03%
Gross profit growth (Q)	-10.88%
Gross profit growth 3Y	36.05%
Gross profit growth 5Y	16.12%
Net income growth	138.7%
Net income growth (Q)	-31.9%
Net income growth (QoQ)	-34.89%
Net income growth 3Y	1.13%
Net income growth 5Y	38.67%
Net income growth years	1
OCF growth	28.07%
OCF growth (Q)	-49.34%
OCF growth (QoQ)	-32.55%
OCF growth 10Y	13.96%
OCF growth 3Y	27.08%
OCF growth 5Y	17.73%
Operating income growth	104.04%
Operating income growth (Q)	-5.15%
Operating income growth 3Y	26.74%
Operating income growth 5Y	8.59%
Revenue growth	4.27%
Revenue growth (Q)	-9.82%
Revenue growth (QoQ)	-3.5%
Revenue growth 10Y	3.97%
Revenue growth 3Y	35.66%
Revenue growth 5Y	17.06%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -61,064
Depreciation and amortization	CAD 9.5M
EBIT	CAD 28M
EBITDA	CAD 37.6M
EPS	CAD 1.59
FCF per share	CAD 1.51
Financing cash flow	CAD -40M
Free cash flow	CAD 38.4M
Free cash flow minus SBC	CAD 36M
Gross profit	CAD 57.4M
Income taxes	CAD -16.4M
Investing cash flow	CAD -1.2M
Net borrowing	CAD -35.5M
Net cash flow	CAD -3.2M
Net income	CAD 41.2M
Operating cash flow minus SBC	CAD 36M
Operating income	CAD 28M
Revenue	CAD 70.5M
Stock-based compensation	CAD 2.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	10.46
Book value per share	CAD 7.67
Debt / EBITDA	0.01
Debt / equity	0
Debt / FCF	0.01
Goodwill	CAD 24.5M
Interest coverage	51.11
Long-term assets	CAD 179.3M
Long-term liabilities	CAD 502,940
Net cash (debt)	CAD 12.4M
Net cash / market cap	3.73%
Net debt / EBITDA	-0.33
Net debt / equity	-0.06
Net debt / FCF	-0.32
Piotroski F-Score	4
Property, plant and equipment	CAD 579,612
Shareholders' equity	CAD 194.9M
Tangible book value	CAD 71.6M
Tangible book value per share	CAD 2.82
Total assets	CAD 222.8M
Total cash	CAD 12.9M
Total debt	CAD 521,177
Total liabilities	CAD 27.9M
WACC	6.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.32
Current assets	CAD 43.5M
Current liabilities	CAD 27.4M
Current ratio	1.59
Inventory turnover	1.25
Net working capital	CAD 3.7M
Quick ratio	1.09
Working capital	CAD 16.3M
Working capital turnover	5.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.02%
Shareholder yield	1.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	192.19%
10Y return CAGR	11.32%
10Y total return	192.19%
150-day SMA	CAD 16.09
15Y price change	1,542.68%
15Y return CAGR	20.51%
15Y total return	1,542.68%
1D price change	2.75%
1M price change	-3.02%
1M total return	-3.02%
1W price change	1.66%
1W total return	1.66%
1Y price change	-7.42%
1Y return CAGR	-7.43%
1Y total return	-7.42%
20-day SMA	CAD 13.49
200-day SMA	CAD 15.85
20Y price change	349%
20Y return CAGR	7.8%
20Y total return	349%
3M price change	-18.02%
3M total return	-18.02%
3Y price change	208.95%
3Y return CAGR	45.63%
3Y total return	208.95%
50-day SMA	CAD 13.95
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 20.56
52-week high date	2026-05-08
52-week low	CAD 12.48
52-week low date	2025-11-07
5Y price change	432.41%
5Y return CAGR	39.72%
5Y total return	432.41%
6M price change	-27.23%
6M total return	-27.23%
All-time high	CAD 20.56
All-time high date	2026-05-08
All-time low	CAD 0.26
All-time low date	2008-10-29
Average true range (ATR)	CAD 0.32
Average volume	16.1K
Beta (5Y)	0.41
Change from 52-week high	-34.48%
Change from 52-week low	7.93%
Change from all-time high	-34.48%
Change from all-time low	5,080.77%
Change from open	1.05%
Day's gap	1.68%
Dollar volume	CAD 84,457
High price	CAD 13.50
Low price	CAD 13.27
Monthly RSI	48.85
Open price	CAD 13.33
Position in 52-week range	86.96%
Previous close	CAD 13.11
Price vs 150-day SMA	-16.28%
Price vs 20-day SMA	-0.16%
Price vs 200-day SMA	-15.04%
Price vs 50-day SMA	-3.41%
Relative volume	0.39
RSI	45.48
Sharpe ratio	-0.07
Sharpe ratio (3Y)	0.92
Sharpe ratio (5Y)	0.85
Sortino ratio	0.03
Sortino ratio (3Y)	1.64
Sortino ratio (5Y)	1.49
Volume	6.3K
Weekly RSI	37.91
YTD price change	-10.56%
YTD total return	-10.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14.8M
Shares change (QoQ)	0.71%
Shares change (YoY)	-1.02%
Shares held by insiders	4.03%
Shares held by institutions	1.5%
Shares outstanding	25.4M

Deeper analysis on TSX/CPH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/CPH report

Is a complete TSX/CPH research report available?

No complete published report is available for tsx/CPH (TSX/CPH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/CPH (TSX/CPH)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/CPH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/CPH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/CPH

Frequently asked questions